E-lombactifs: Evaluation of the Impact a Smartphone Application on Adherence an Exercise Program in Chronic Low Back Pain (E-lombactifs)

February 13, 2024 updated by: University Hospital, Clermont-Ferrand

The main objective is to assess the impact of smartphone application on adherence to a physical exercise program in chronic low back pain patients.

Adherence to a physical exercise program will be assessed at the start of the protocol, at three weeks and six months.

A control group will benefit from conventional care in a rehabilitation center and an intervention group will benefit from a conventional care in a rehabilitation center accompanied by education in the use of a smartphone application including physical exercises and information about low back pain.

The hypothesis of the search is that adherence is better in intervention group than control group at 6 months due to education in the use of smartphone application.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • CHU Clermont Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult People
  • With nonspecific chronic low back pain (according to the definition of the HAS)
  • Covered under the national health insurance
  • Giving informed written consent to participate in the study

Exclusion Criteria:

  • Patient who do not meet the diagnostic criteria according to the definition of HAS
  • Behavioral disorders or comprehension difficulties making assessment impossible
  • Patient with a contraindication to physical exercise for medical reasons
  • Patient under guardianship, curatorship or safeguard of justice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group application (GA)
benefit from conventional care in a rehabilitation center, therapeutic education program and education in the use of the smartphone application "mon coach dos"
In addition to conventional care and the therapeutic education program, GA will benefit from three education sessions (one per week) on the use of the smartphone app mon coach dos
conventional care and the therapeutic education program
Active Comparator: Groupe conventional care (GCC)
benefit from conventional care in a rehabilitation center and therapeutic education program
conventional care and the therapeutic education program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EARS : exercise adherence rating scale
Time Frame: day1
EARS assess the adherence in physical activity program.
day1
EARS : exercise adherence rating scale
Time Frame: day 15
EARS assess the adherence in physical activity program.
day 15
EARS : exercise adherence rating scale
Time Frame: day 180
EARS assess the adherence in physical activity program.
day 180

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
OSWESTRY questionnaire
Time Frame: day1, day 15, day 180
Disability is measured by OSWESTRY
day1, day 15, day 180
EPAP questionnaire
Time Frame: day1, day 15, day 180
The perceived barriers to and facilitators of physical activity are measured by EPAP
day1, day 15, day 180
Pain measurment: numeric scale
Time Frame: day1, day 15, day 180
The pain is measured by numeric scale
day1, day 15, day 180
6 minutes' walk test (6MWT)
Time Frame: day1, day 15, day 180
Aerobic and functional capacities are measured by 6 minutes' walk test (6MWT)
day1, day 15, day 180
aerobic capacities
Time Frame: day1, day 15, day 180
aerobic capacities are measured by sub maximal ergocycle test
day1, day 15, day 180
muscular endurance
Time Frame: day1, day 15, day 180
the muscular endurance of the erector muscles of the spine is measured by Sorensen test
day1, day 15, day 180
muscular endurance of the flexor muscles of the spine
Time Frame: day1, day 15, day 180
the muscular endurance of the flexor muscles of the spine is measured by ITO test
day1, day 15, day 180
muscular endurance of the extensor of the knee
Time Frame: day1, day 15, day 180
the muscular endurance of the extensor of the knee is measured by Killy test
day1, day 15, day 180
Core measurment
Time Frame: day1, day 15, day 180
Core is measured by plank test
day1, day 15, day 180
Flexibility on posterior chain
Time Frame: day1, day 15, day 180
Flexibility on posterior chain is measured by DDS test
day1, day 15, day 180
Mobility on posterior chain
Time Frame: day1, day 15, day 180
Mobility on posterior chain is measured by Schober test
day1, day 15, day 180

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-Baptiste Lechauve, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 9, 2020

Primary Completion (Actual)

December 18, 2023

Study Completion (Actual)

December 18, 2023

Study Registration Dates

First Submitted

February 7, 2020

First Submitted That Met QC Criteria

February 10, 2020

First Posted (Actual)

February 11, 2020

Study Record Updates

Last Update Posted (Estimated)

February 14, 2024

Last Update Submitted That Met QC Criteria

February 13, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RBHP 2019 LECHAUVE
  • 2019-A02191-56 (Other Identifier: 2019-A02191-56)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on Education in the use of smartphone app (Mon coach dos)

3
Subscribe